Singular Genomics Systems Inc (OMIC)
22.75
+0.22
(+0.98%)
USD |
NASDAQ |
Nov 14, 16:00
22.77
+0.02
(+0.09%)
Pre-Market: 08:20
Singular Genomics Systems Cash from Operations (Quarterly): -18.04M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -18.04M |
| March 31, 2024 | -23.70M |
| December 31, 2023 | -18.90M |
| September 30, 2023 | -16.81M |
| June 30, 2023 | -20.00M |
| March 31, 2023 | -17.93M |
| December 31, 2022 | -19.92M |
| September 30, 2022 | -21.79M |
| June 30, 2022 | -25.55M |
| Date | Value |
|---|---|
| March 31, 2022 | -19.84M |
| December 31, 2021 | -15.70M |
| September 30, 2021 | -10.98M |
| June 30, 2021 | -15.84M |
| March 31, 2021 | -9.185M |
| December 31, 2020 | -6.986M |
| September 30, 2020 | -6.665M |
| June 30, 2020 | -6.513M |
| March 31, 2020 | -4.709M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-25.55M
Minimum
Jun 2022
-4.709M
Maximum
Mar 2020
-15.50M
Average
-17.37M
Median
Cash from Operations (Quarterly) Benchmarks
| Bruker Corp | 38.40M |
| Azenta Inc | 1.791M |
| Harvard Bioscience Inc | -0.842M |
| Bionano Genomics Inc | -20.98M |
| Akoya Biosciences Inc | -11.04M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 23.96M |
| Cash from Financing (Quarterly) | 0.08M |
| Free Cash Flow | -77.98M |
| Free Cash Flow Per Share (Quarterly) | -7.272 |
| Free Cash Flow to Equity (Quarterly) | -16.77M |
| Free Cash Flow Yield | -139.4% |